Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities
- PMID: 23391514
- PMCID: PMC3659183
- DOI: 10.1016/j.mrfmmm.2012.12.008
Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities
Abstract
The field of DNA mismatch repair (MMR) has rapidly expanded after the discovery of the MutHLS repair system in bacteria. By the mid 1990s yeast and human homologues to bacterial MutL and MutS had been identified and their contribution to hereditary non-polyposis colorectal cancer (HNPCC; Lynch syndrome) was under intense investigation. The human MutS homologue 6 protein (hMSH6), was first reported in 1995 as a G:T binding partner (GTBP) of hMSH2, forming the hMutSα mismatch-binding complex. Signal transduction from each DNA-bound hMutSα complex is accomplished by the hMutLα heterodimer (hMLH1 and hPMS2). Molecular mechanisms and cellular regulation of individual MMR proteins are now areas of intensive research. This review will focus on molecular mechanisms associated with mismatch binding, as well as emerging evidence that MutSα, and in particular, MSH6, is a key protein in MMR-dependent DNA damage response and communication with other DNA repair pathways within the cell. MSH6 is unstable in the absence of MSH2, however it is the DNA lesion-binding partner of this heterodimer. MSH6, but not MSH2, has a conserved Phe-X-Glu motif that recognizes and binds several different DNA structural distortions, initiating different cellular responses. hMSH6 also contains the nuclear localization sequences required to shuttle hMutSα into the nucleus. For example, upon binding to O(6)meG:T, MSH6 triggers a DNA damage response that involves altered phosphorylation within the N-terminal disordered domain of this unique protein. While many investigations have focused on MMR as a post-replication DNA repair mechanism, MMR proteins are expressed and active in all phases of the cell cycle. There is much more to be discovered about regulatory cellular roles that require the presence of MutSα and, in particular, MSH6.
Copyright © 2013 Elsevier B.V. All rights reserved.
Figures



Similar articles
-
Biochemical analysis of the human mismatch repair proteins hMutSα MSH2(G674A)-MSH6 and MSH2-MSH6(T1219D).J Biol Chem. 2012 Mar 23;287(13):9777-9791. doi: 10.1074/jbc.M111.316919. Epub 2012 Jan 25. J Biol Chem. 2012. PMID: 22277660 Free PMC article.
-
Saccharomyces cerevisiae Msh2-Msh6 DNA binding kinetics reveal a mechanism of targeting sites for DNA mismatch repair.Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):680-5. doi: 10.1073/pnas.0908302107. Epub 2009 Dec 22. Proc Natl Acad Sci U S A. 2010. PMID: 20080735 Free PMC article.
-
The properties of Msh2-Msh6 ATP binding mutants suggest a signal amplification mechanism in DNA mismatch repair.J Biol Chem. 2018 Nov 23;293(47):18055-18070. doi: 10.1074/jbc.RA118.005439. Epub 2018 Sep 20. J Biol Chem. 2018. PMID: 30237169 Free PMC article.
-
Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome.Int J Clin Oncol. 2019 Sep;24(9):999-1011. doi: 10.1007/s10147-019-01494-y. Epub 2019 Jul 4. Int J Clin Oncol. 2019. PMID: 31273487 Review.
-
Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis.Eur J Cancer Prev. 2014 Jul;23(4):246-57. doi: 10.1097/CEJ.0000000000000019. Eur J Cancer Prev. 2014. PMID: 24614649 Review.
Cited by
-
Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.Front Oncol. 2018 Jun 18;8:226. doi: 10.3389/fonc.2018.00226. eCollection 2018. Front Oncol. 2018. PMID: 29967761 Free PMC article. Review.
-
Mismatch repair single nucleotide polymorphisms and thyroid cancer susceptibility.Oncol Lett. 2018 May;15(5):6715-6726. doi: 10.3892/ol.2018.8103. Epub 2018 Feb 21. Oncol Lett. 2018. PMID: 29616133 Free PMC article.
-
The type of DNA damage response after decitabine treatment depends on the level of DNMT activity.Life Sci Alliance. 2024 Jun 21;7(9):e202302437. doi: 10.26508/lsa.202302437. Print 2024 Sep. Life Sci Alliance. 2024. PMID: 38906675 Free PMC article.
-
HER2 Overexpression and Mismatch Repair Deficiency are Correlated with Malignancy in Colorectal Cancer.Cancer Manag Res. 2021 Apr 20;13:3443-3454. doi: 10.2147/CMAR.S297596. eCollection 2021. Cancer Manag Res. 2021. PMID: 33907467 Free PMC article.
-
CK2 and the Hallmarks of Cancer.Biomedicines. 2022 Aug 16;10(8):1987. doi: 10.3390/biomedicines10081987. Biomedicines. 2022. PMID: 36009534 Free PMC article. Review.
References
-
- Iyer RR, Pluciennik A, Burdett V, Modrich P. DNA mismatch repair: functions and mechanisms. Chemical Review. 2006;106:302–323. - PubMed
-
- Jiricny J. The multifacteted mismatch-repair system. Nature Reviews: Molecular Cell Biology. 2006;7:335–346. - PubMed
-
- Kunkel TA, Erie DA. DNA mismatch repair. Annual Review Biochemistry. 2005;74:681–710. - PubMed
-
- Au KG, Welsh K, Modrich P. Initiation of methyl-directed mismatch repair. Journal of Biological Chemistry. 1992;267:12142–12148. - PubMed
-
- Modrich P. Mechanisms and biological effects of mismatch repair. Annu. Rev. Genet. 1991;25:229–253. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous